Andrew Carson-Stevens

Cardiff University - Centre for Trials Research

Cardiff

United Kingdom

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 12,418

SSRN RANKINGS

Top 12,418

in Total Papers Downloads

7,899

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial

Number of pages: 43 Posted: 17 Oct 2022
University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Oxford Respiratory Trials Unit, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford - Nuffield Department of Primary Care Health Sciences, University College London - UCL Institute of Immunity and Transplantation, University College London - Department of Infection, Inflammation and Immunity, University College London - Department of Infection, Inflammation and Immunity, University of Liverpool - Department of Molecular and Clinical Pharmacology, University of Oxford - Nuffield Department of Primary Care Health Sciences, Cardiff University - Centre for Trials Research, University of Nottingham - Division of Epidemiology and Public Health, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, Berry Consultants, LLC, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, Windrush Medical Practice, University of Exeter - Faculty of Health and Life Sciences, University of Oxford - Oxford Respiratory Trials Unit, Cardiff University - Centre for Trials Research, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, Berry Consultants, LLC, Berry Consultants, LLC, Berry Consultants, LLC, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Glasgow - Institute of Health and Wellbeing, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, NHS Foundation Trust - Oxford University Hospitals, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, North Manchester General Hospital - Regional Infectious Diseases Unit, Cardiff University - Centre for Trials Research, University of Oxford - Nuffield Department of Primary Care Health Sciences and University of Southampton - Primary Care and Population Science
Downloads 4,298 (4,889)

Abstract:

Loading...

COVID-19, clincial trial, antiviral agents, primary health care, molnupiravir

2.

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

Number of pages: 36 Posted: 30 Sep 2021
University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, University Hospitals Bristol, Cardiff University - Centre for Trials Research, University of Bristol - Bristol Vaccine Centre, University Hospitals Bristol, Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Public Health England - National Infection Service, University of Bristol, University of Bristol, University of Bristol, University of Bristol, National Health Service, United Kingdom, University College London, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University Hospitals Bristol - University Hospitals Bristol NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Great Western Hospitals, The Alverton Practice, University of Bristol, University of Bristol, University of Oxford - Centre for Vaccinology and Tropical Medicine, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), University of Nottingham - Division of Epidemiology and Public Health, University of Bristol - Bristol Vaccine Centre, University of Bristol and Independent
Downloads 3,400 (7,173)

Abstract:

Loading...

Concomitant vaccination, COVID-19 vaccine, Influenza vaccine, Clinical Trial

3.

Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months

Number of pages: 38 Posted: 07 May 2024
University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Oxford Respiratory Trials Unit, University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University College London - UCL Institute of Immunity and Transplantation, University College London, University College London - Department of Infection, Inflammation and Immunity, University of Liverpool, University of Oxford - Nuffield Department of Primary Care Health Sciences, Cardiff University, Cardiff University, Cardiff University - Centre for Trials Research, University of Nottingham, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, University of Southampton - Primary Care Research Centre, Windrush Medical Practice, University of Exeter - Faculty of Health and Life Sciences, University of Oxford - Oxford Respiratory Trials Unit, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Glasgow - Institute of Health and Wellbeing, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, North Manchester General Hospital - Regional Infectious Diseases Unit, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton, University of Oxford - Nuffield Department of Primary Care Health Sciences and Independent
Downloads 157 (380,726)
Citation 1

Abstract:

Loading...

SARS-CoV-2, Primary Care, COVID-19, Randomized controlled trial, Long term follow-up

4.

What Were the Effects of the UK's COVID-19 Public Health Policy 'Shielding'? Results of Linked Data Matched Cohort Study

Number of pages: 29 Posted: 19 Jun 2024
Swansea University, Swansea University - Population Data Science, Cardiff University - Centre for Trials Research, University of Warwick, Swansea University, Cardiff University, Swansea University, Swansea University, Swansea University - Population Data Science, Digital Health and Care Wales, Cardiff University, Swansea University - Population Data Science, Swansea University - Population Data Science, Swansea University, UK Health Security Agency, Swansea University, Swansea University and Swansea University
Downloads 44 (820,511)

Abstract:

Loading...

COVID-19, Pandemic, Shielding, Routine Linked Data, Self-Reported Outcomes